Justin M. Watts, MD, is a hematologist-oncologist specializing in malignant hematology. He serves as Chief of the Leukemia Section in the Division of Hematology at Sylvester Comprehensive Cancer Center and is an Associate Professor of Clinical Medicine at the University of Miami Miller School of Medicine. His clinical practice centers on myeloid malignancies, precision-guided treatment strategies for blood cancers, and the integration of targeted and immune-based therapies. Dr. Watts’ research focuses on epigenetic therapeutics, molecularly targeted drug development, and early-phase clinical trial design to advance more effective and less toxic treatment approaches. He is Co-Leader of the Phase 1 Clinical Trials Program at Sylvester, holds the Pap Corps Endowed Professorship in Leukemia, and has received grant support from the NIH, NCI, and the Leukemia & Lymphoma Society. He has also contributed to the clinical development leading to FDA approval of olutasidenib. He earned his MD, magna cum laude, from Emory University School of Medicine, completed an Internal Medicine residency at the University of California, San Francisco, and trained in Hematology & Medical Oncology at Memorial Sloan Kettering Cancer Center and Weill Cornell Medical College.
Associate Professor
Medical School
2002 – 2007
Residency
2007 – 2010
Fellowship
2010 – 2014